Connect with us

Business

UPDATE 3-Pfizer, Moderna COVID-19 vaccines highly effective after first shot in real-world use, -U.S. study – Yahoo

Published

 on


GlobeNewswire

The Worldwide Uninterrupted Power Supply System Industry is Expected to Reach $9.4 Billion by 2026 at a CAGR of 4.3% from 2020

Dublin, March 30, 2021 (GLOBE NEWSWIRE) — The “Uninterrupted Power Supply System Market by Type, Rating and End User: Opportunity Analysis and Industry Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering. The global uninterrupted power supply market was valued at $7.4 billion in 2019, and is projected to reach $9.4 billion by 2027, growing at a CAGR of 4.3% from 2020 to 2027.Uninterrupted power supply is battery backup system, which is used as immediate power source for the connected load during any failure in the main input power source. This is used as temporary power supply to ensure orderly shutdown of electrical appliances. Uninterrupted power supply used with hardware systems can help to prevent serious damage in the hardware during frequent power loss. UPS is widely used in different sectors including data centers, industries, telecommunications, and hospitals.The market is driven by increase in need for reliable and high quality energy solutions for different industries including data centers, telecommunication etc. UPS allow business organizations to run facilitates under power shortage. In addition, the growing population and frequent power failures for both commercial and residential sectors will positively impact the market growth. Furthermore, emerging economies, such as China, India, and Japan are actively investing in uninterrupted power supply market which will further impact the market scenario. However, the high cost of online UPS and high maintenance cost of UPS system may impede the market growth in residential sector. Nonetheless, advancements in UPS battery systems, such as new Lithium-ion (Li-ion) batteries with high operating temperature will create lucrative opportunities in the market.The global uninterrupted power supply market is segmented on the basis of type, rating, and end user. On the basis of type, it is divided into online, offline and line interactive. The offline UPS systems accounted for significant market share, owing to significant demand in small scale and medium scale applications for computers, printers, or scanners Based on rating, it is categorized into (< 5KVA, 5-< 50 KVA, 50-200 KVA, and >200 KVA. The >200 KVA rating UPS system accounted for significant revenue share. This is attributed to growing application in commercial and industrial end-user segments for various heavy appliances. Based on end user, it is segmented into residential, industrial, and commercial. Industrial sector accounted for highest market share, owing to rise in demand for reliable energy solutions. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA, with country level analysis of each region.Major players have adopted product launch and agreements to sustain the intense market competition. For instance, in March 2019, Eaton Corporation launched Eaton 5P UPS system which can be used as a tower UPS, wall mount UPS, and rackmount UPS. This product launch enhanced company’s market presence in IT and data center reducing the maintenance cost. The key players profiled in the report include Schneider Electric Se, Abb Ltd., Soro Electronics, Luminous power technologies, MicROTEK, Delta Electronics Inc, Emersion Electric Co., and Huawei Technologies Co., Ltd.COVID-19 scenario analysis: The global uninterrupted power supply market witnessed significant surge in demand during this pandemic period. This is attributed to social distancing and work from home norms, which increased the demand in residential end-user segment.In addition, large number of power plants and substations were operating with limited workforce, which led to frequent power loss.Such power shortage during this pandemic led to increase in demand for UPS systems for residential as well as industrial sectors.However, due to restrictions on cross border export and import, the UPS supply chain have been negatively affectedMoreover, the delay in upstream and downstream channels lead to increase in the inventory carrying cost. Key Benefits for Stakeholders: The global uninterrupted power supply market analysis covers in-depth information of major industry participants.Porter’s five forces analysis helps to analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.Major countries have been mapped according to their individual revenue contribution to the regional market.The report provides in-depth analysis of the global uninterrupted power supply market for the period 2020-2027.The report outlines the current global uninterrupted power supply market trends and future estimations of the global uninterrupted power supply market from 2019 to 2027 to understand the prevailing opportunities and potential investment pockets.Key drivers, restraints & opportunities and their detailed impact analysis of the global uninterrupted power supply market are explained in the study. Key Topics Covered: CHAPTER 1: INTRODUCTION1.1. Report description1.2. Key benefits for Stakeholders1.3. Key Market Segments1.4. Research methodology1.4.1. Primary research1.4.2. Secondary research1.4.3. Analyst tools and modelsCHAPTER 2: EXECUTIVE SUMMARY2.1. Key findings of the study2.2. CXO perspectiveCHAPTER 3: MARKET LANDSCAPE3.1. Market definition and scope3.2. Key findings3.2.1. Top investment pockets3.3. Porter’s five forces analysis3.4. Market share analysis & Top player positioning, 20193.4.1. Top player positioning, 20193.5. Market dynamics3.5.1. Drivers3.5.1.1. Increase in demand for reliable power solutions3.5.1.2. Increase in disposable income3.5.2. Restraint3.5.2.1. High maintenance cost of UPS systems3.5.3. Opportunity3.5.3.1. Advancement in UPS battery systems3.6. Impact of Covid-19 Outburst on Uninterrupted Power Supply (UPS) System MarketCHAPTER 4: UNINTERRUPTED POWER SUPPLY (UPS) SYSTEM MARKET, BY TYPE4.1. Overview4.1.1. Market size and forecast4.2. Online4.2.1. Key market trends, growth factors, and opportunities4.2.2. Market size and forecast, by region4.3. Offline4.3.1. Key market trends, growth factors, and opportunities4.3.2. Market size and forecast, by region4.4. Line interactive4.4.1. Key market trends, growth factors, and opportunities4.4.2. Market size and forecast, by regionCHAPTER 5: UNINTERRUPTED POWER SUPPLY (UPS) SYSTEM MARKET, BY RATING5.1. Overview5.1.1. Market size and forecast5.2.< 5 KVA5.2.1. Key market trends, growth factors, and opportunities5.2.2. Market size and forecast, by region5.3.5-< 50 KVA5.3.1. Key market trends, growth factors, and opportunities5.3.2. Market size and forecast, by region5.4.50-200 KVA5.4.1. Key market trends, growth factors, and opportunities5.4.2. Market size and forecast, by region5.5.>200 KVA5.5.1. Key market trends, growth factors, and opportunities5.5.2. Market size and forecast, by regionCHAPTER 6: UNINTERRUPTED POWER SUPPLY (UPS) SYSTEM MARKET, BY RATING6.1. Overview6.1.1. Market size and forecast6.2. Residential6.2.1. Key market trends, growth factors, and opportunities6.2.2. Market size and forecast, by region6.3. Industrial6.3.1. Key market trends, growth factors, and opportunities6.3.2. Market size and forecast, by region6.4. Commercial6.4.1. Key market trends, growth factors, and opportunities6.4.2. Market size and forecast, by regionCHAPTER 7: UNINTERRUPTED POWER SUPPLY (UPS) SYSTEM MARKET, BY REGION7.1. Overview7.2. North America7.3. Europe7.4. Asia-Pacific7.5. LAMEACHAPTER 8: COMPETITIVE LANDSCAPE8.1. Introduction8.2. Product mapping of top 10 players8.3. Competitive Heatmap8.4. Key development8.4.1. Agreement8.4.2. Product LaunchCHAPTER 9: COMPANY PROFILES9.1. Schneider Electric SE9.1.1. Company overview9.1.2. Company Snapshot9.1.3. Operating business segments9.1.4. Product Portfolio9.1.5. Business performance9.1.6. Key strategic moves and developments9.2. ABB Ltd.9.2.1. Company overview9.2.2. Company Snapshot9.2.3. Operating business segments9.2.4. Product portfolio9.2.5. Business performance9.2.6. Key strategic moves and developments9.3. SORO Electronics9.3.1. Company overview9.3.2. Company snapshot9.3.3. Operating business segments9.3.4. Product Portfolio9.4. Luminous Power Technologies9.4.1. Company overview9.4.2. Company snapshot9.4.3. Operating business segments9.4.4. Product Portfolio9.5. Microtek9.5.1. Company overview9.5.2. Company snapshot9.5.3. Operating business segments9.5.4. Product Portfolio9.6. Delta Electronics, Inc.9.6.1. Company overview9.6.2. Company snapshot9.6.3. Operating business segments9.6.4. Product Portfolio9.6.5. Business performance9.7. Emerson Electric Co.9.7.1. Company overview9.7.2. Company snapshot9.7.3. Operating business segments9.7.4. Product portfolio9.7.5. Business performance9.8. Huawei Technologies Co., Ltd.9.8.1. Company overview9.8.2. Company snapshot9.8.3. Operating business segments9.8.4. Product Portfolio9.8.5. Business performance9.8.6. Key strategic moves and developments9.9. Eaton Corporation9.9.1. Company overview9.9.2. Company snapshot9.9.3. Operating business segments9.9.4. Product portfolio9.9.5. Business performance9.9.6. Key strategic moves and developments9.10. Legrand9.10.1. Company overview9.10.2. Company snapshot9.10.3. Operating business segments9.10.4. Product portfolio9.10.5. Business performance9.10.6. Key strategic moves and developmentsFor more information about this report visit https://www.researchandmarkets.com/r/uvq535 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Let’s block ads! (Why?)



Source link

Continue Reading

Business

CANADA STOCKS – TSX falls 0.14% to 19,201.28

Published

 on

* The Toronto Stock Exchange’s TSX falls 0.14 percent to 19,201.28

* Leading the index were Stantec Inc <STN.TO​>, up 3.4%, Imperial Oil Ltd​, up 3.3%, and Corus Entertainment Inc​, higher by 2.9%.

* Lagging shares were Aphria Inc​​, down 14.2%, Village Farms International Inc​, down 9.9%, and Aurora Cannabis Inc​, lower by 9.4%.

* On the TSX 91 issues rose and 134 fell as a 0.7-to-1 ratio favored decliners. There were 24 new highs and no new lows, with total volume of 228.0 million shares.

* The most heavily traded shares by volume were Toronto-dominion Bank, Royal Bank Of Canada and Suncor Energy Inc.

* The TSX’s energy group fell 0.32 points, or 0.3%, while the financials sector climbed 2.46 points, or 0.7%.

* West Texas Intermediate crude futures rose 0.52%, or $0.31, to $59.63 a barrel. Brent crude  rose 0.4%, or $0.25, to $63.2 [O/R]

* The TSX is up 10.1% for the year.

Continue Reading

Business

Air Canada signs C$5.9 billion government aid package, agrees to buy Airbus, Boeing jets

Published

 on

By David Ljunggren and Allison Lampert

OTTAWA/MONTREAL (Reuters) -Air Canada, struggling with a collapse in traffic due to the COVID-19 pandemic, reached a deal on Monday on a long-awaited aid package with the federal government that would allow it to access up to C$5.9 billion ($4.69 billion) in funds.

The agreement – the largest individual coronavirus-related loan that Ottawa has arranged with a company – was announced after the airline industry criticized Prime Minister Justin Trudeau’s Liberal government for dawdling. The United States and France acted much more quickly to help major carriers.

Canada‘s largest carrier, which last year cut over half its workforce, or 20,000 jobs, and other airlines have been negotiating with the government for months on a coronavirus aid package.

In February, Air Canada reported a net loss for 2020 of C$4.65 billion, compared with a 2019 profit of C$1.48 billion.

As part of the deal, Air Canada agreed to ban share buybacks and dividends, cap annual compensation for senior executives at C$1 million a year and preserve jobs at the current level, which is 14,859.

It will also proceed with planned purchases of 33 Airbus SE 220 airliners and 40 Boeing Co 737 MAX airliners.

Chris Murray, managing director, equity research at ATB Capital Markets, said the deal took into account the “specific needs of Air Canada in the short and medium term without being overly onerous.”

He added: “It gives them some flexibility in drawing down additional liquidity as needed.”

Transport Minister Omar Alghabra said the government was still in negotiations with other airlines about possible aid.

Canada, the world’s second-largest nation by area, depends heavily on civil aviation to keep remote communities connected.

Opposition politicians fretted that further delays in announcing aid could result in permanent damage to the country.

Air Canada said it would resume services on nearly all of the routes it had suspended because of COVID-19.

‘SIGNIFICANT LAYER OF INSURANCE’

The deal removes a potential political challenge for the Liberals, who insiders say are set to trigger an election later this year.

The government has agreed to buy C$500 million worth of shares in the airline, at C$23.1793 each, or a 14.2% discount to Monday’s close, a roughly 6% stake.

“Maintaining a competitive airline sector and good jobs is crucially important,” Finance Minister Chrystia Freeland told reporters, adding the equity stake would allow taxpayers to benefit when the airline’s fortunes recovered.

The Canadian government previously approved similar loans for four other companies worth up to C$1.billion, including up to C$375 million to low-cost airline Sunwing Vacations Inc. The government has paid out C$73.47 billion under its wage subsidy program and C$46.11 billion in loans to hard-hit small businesses.

Michael Rousseau, Air Canada‘s president and chief executive officer, said the liquidity “provides a significant layer of insurance for Air Canada.”

Jerry Dias, head of the Unifor private-sector union, described the announcement as “a good deal for everybody.”

Unifor represents more than 16,000 members working in the air transportation sector.

But the Canadian Union of Public Employees, which represents roughly 10,000 Air Canada flight attendants, said the package protected the jobs of current workers rather than the 7,500 members of its union who had been let go by the carrier.

($1=1.2567 Canadian dollars)

(Reporting by David Ljunggren in Ottawa and Allison Lampert in Montreal; Additional reporting by Julie Gordon in Ottawa and Munsif Vengattil in Bengaluru; Editing by Dan Grebler and Peter Cooney)

Continue Reading

Business

U.K. advises limiting AstraZeneca in under-30s amid clot worry

Published

 on

LONDON —
British authorities recommended Wednesday that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence that the shot may be linked to rare blood clots.

The recommendation came as regulators both in the United Kingdom and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people — even though the European Medicines Agency said it had found a “possible link” between the shot and the rare clots. British authorities recommended that people under 30 be offered alternatives to AstraZeneca. But the EMA advised no such age restrictions, leaving it up to its member-countries to decide whether to limit its use.

Several countries have already imposed limits on who can receive the vaccine, and any restrictions are closely watched since the vaccine, which is cheaper and easier to store than many others, is critical to global immunization campaigns and is a pillar of the UN-backed program known as COVAX that aims to get vaccines to some of the world’s poorest countries.

“This is a course correction, there’s no question about that,” Jonathan Van-Tam, England’s deputy chief medical officer, said during a press briefing. “But it is, in a sense, in medicine quite normal for physicians to alter their preferences for how patients are treated over time.”

Van-Tam said the effect on Britain’s vaccination timetable — one of the speediest in the world — should be “zero or negligible,” assuming the National Health Service receives expected deliveries of other vaccines, including those produced by Pfizer and Moderna.

EU and U.K. regulators held simultaneous press conferences Wednesday afternoon to announce the results of investigations into reports of blood clots that sparked concern about the rollout of the AstraZeneca vaccine.

The EU agency described the clots as “very rare” side effects. Dr Sabine Straus, chair of EMA’s Safety Committee, said the best data is coming from Germany where there is one report of the rare clots for every 100,000 doses given, although she noted far fewer reports in the U.K. Still, that’s less than the clot risk that healthy women face from birth control pills, noted another expert, Dr. Peter Arlett.

The agency said most of the cases reported have occurred in women under 60 within two weeks of vaccination — but based on the currently available evidence, it was not able to identify specific risk factors. Experts reviewed several dozen cases that came mainly from Europe and the U.K., where around 25 million people have received the AstraZeneca vaccine.

“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” said Emer Cooke, the agency’s executive director. “The risk of mortality from COVID is much greater than the risk of mortality from these side effects.”

Arlett said there is no information suggesting an increased risk from the other major COVID-19 vaccines.

The EMA’s investigation focused on unusual types of blood clots that are occurring along with low blood platelets. One rare clot type appears in multiple blood vessels and the other in veins that drain blood from the brain.

While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced” among younger people who are less likely to become seriously ill with COVID-19, the U.K’s Van-Tam said.

“We are not advising a stop to any vaccination for any individual in any age group,” said Wei Shen Lim, who chairs Britain’s Joint Committee on Vaccination and Immunization. “We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution rather than because we have any serious safety concerns.”

In March, more than a dozen countries, mostly in Europe, suspended their use of AstraZeneca over the blood clot issue. Most restarted — some with age restrictions — after the EMA said countries should continue using the potentially life-saving vaccine.

Britain, which relies heavily on AstraZeneca, however, continued to use it.

The suspensions were seen as particularly damaging for AstraZeneca because they came after repeated missteps in how the company reported data on the vaccine’s effectiveness and concerns over how well its shot worked in older people. That has led to frequently changing advice in some countries on who can take the vaccine, raising worries that AstraZeneca’s credibility could be permanently damaged, spurring more vaccine hesitancy and prolonging the pandemic.

Dr. Peter English, who formerly chaired the British Medical Association’s Public Health Medicine Committee, said the back-and-forth over the AstraZeneca vaccine globally could have serious consequences.

“We can’t afford not to use this vaccine if we are going to end the pandemic,” he said.

In some countries, authorities have already noted hesitance toward the AstraZeneca shot.

“People come and they are reluctant to take the AstraZeneca vaccine, they ask us if we also use anything else,” said Florentina Nastase, a doctor and co-ordinator at a vaccination centre in Bucharest, Romania. “There were cases in which people (scheduled for the AstraZeneca) didn’t show up, there were cases when people came to the centre and saw that we use only AstraZeneca and refused (to be inoculated).”

Meanwhile, the governor of Italy’s northern Veneto region had said earlier Wednesday that any decision to change the guidance on AstraZeneca would cause major disruptions to immunizations — at a time when Europe is already struggling to ramp them up — and could create more confusion about the shot.

“If they do like Germany, and allow Astra Zeneca only to people over 65, that would be absurd. Before it was only for people under 55. Put yourself in the place of citizens, it is hard to understand anything,” Luca Zaia told reporters.

The latest suspension of AstraZeneca came in Spain’s Castilla y Leon region, where health chief Veronica Casado said Wednesday that “the principle of prudence” drove her to put a temporary hold on the vaccine that she still backed as being both effective and necessary.

French health authorities had said they, too, were awaiting EMA’s conclusions, as were some officials in Asia.

On Wednesday, South Korea said it would temporarily suspend the use of AstraZeneca’s vaccine in people 60 and younger. In that age group, the country is only currently vaccinating health workers and people in long-term care settings.

The Korea Disease Control and Prevention Agency said it would also pause a vaccine rollout to school nurses and teachers that was to begin on Thursday, while awaiting the outcome of the EMA’s review.

But some experts urged perspective. Prof Anthony Harnden, the deputy chair of Britain’s vaccination committee, said that the program has saved at least 6,000 lives in the first three months and will help pave the way back to normal life.

“What is clear it that for the vast majority of people the benefits of the Oxford AZ vaccine far outweigh any extremely small risk,” he said. “And the Oxford AZ vaccine will continue to save many from suffering the devastating effects that can result from a COVID infection.”

Source: – CTV News

Source link

Continue Reading

Trending